Synergy CHC Corp. Reports First Quarter 2026 Financial Results
N. WINDHAM, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer...
N. WINDHAM, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer...
Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4...
Update reflects growing clinical evidence and expanded adoption in practiceSAN JOSE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics®...
PALM BEACH GARDENS, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc (“Forward” or “the Company”), a clinical-stage biotechnology...
Cash Position Grows to $25.9 MillionKANSAS CITY, Kan., May 14, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical...
Analysis showed that liposuction followed by helium plasma RF was associated with higher patient-reported satisfaction with abdominal appearance, lower abdominoplasty...
OrganOx enters next phase of growth for continued global expansion and access to life-saving technologyOXFORD, United Kingdom and MADISON, N.J.,...
Multidimensional analyses demonstrate that repeated DeltEx DRI dosing preserves immune function, drives tumor microenvironment remodeling, and correlates with improved survival...
After successful completion of FDA Type C meeting, Clene expects to submit an NDA for CNM-Au8® under the accelerated approval...
Seasoned Biotech CFO with IPO and M&A track record joins as Company advances pivotal Phase 3 trial of sovateltide, RESPECT-ETB,...
Effective Steroids for Beginners that actually work, for (Bulking and Cutting) without side effects, natural anabolic steroid alternatives for muscle...
Antwerp, Belgium, May 14, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today...
, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) today...
Data highlight advancements across ElevateBio's targeted gene insertion platform, powered by retrotransposon and machine learning-optimized recombinase approaches, and its new...
Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron projects...
Jason Nalewany has been appointed as Chief Financial Officer of Custom Health and, following the completion of the Arrangement, the...
May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology...
PALO ALTO, CA / ACCESS Newswire / May 14, 2026 / Bioz, Inc. a leading platform for uniting scientific validation...
Luna Acupuncture & Wellness is expanding its focus on Type 2 diabetes care as more Oregonians search for supportive, non-invasive...
Another major milestone in its continuous global IP strategy, advancing protection of VIVI Cap Smart across international marketsHighlightsGranted Patent covers...